Directori de persones
Marina Laplana Lafaja

Marina Laplana Lafaja

Grau: Doctor/a

973003751
marina.laplana(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/G-2653-2010

Publicacions

  • Laplana, M; Lopez-Ortega, R; Fibla, J

    Polygenic risk score comparator (PRScomp): Test population vs. worldwide populations

    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS 183 -. .

    [doi:10.1016/j.ijmedinf.2023.105333]

  • Chung FF; Maldonado SG; Nemc A; Bouaoun L; Cahais V; Cuenin C; Salle A; Johnson T; Ergüner B; Laplana M; Datlinger P; Jeschke J; Weiderpass E; Kristensen V; Delaloge S; Fuks F; Risch A; Ghantous A; Plass C; Bock C; Kaaks R; Herceg Z

    Buffy coat signatures of breast cancer risk in a prospective cohort study.

    Clinical Epigenetics 15 102-102. .

    [doi:10.1186/s13148-023-01509-6]

  • Fibla J; Maceda I; Laplana M; Guerrero M; Álvarez MM; Burgueño J; Camps A; Fàbrega J; Felisart J; Grané J; Remón JL; Serra J; Moral P; Lao O

    The power of geohistorical boundaries for modeling the genetic background of human populations: The case of the rural catalan Pyrenees.

    Frontiers in Genetics 13 1100440-1100440. .

    [doi:10.3389/fgene.2022.1100440]

  • Laplana, M; Bravo, MJ; Fernandez-Fuertes, M; Ruiz-Garcia, C; Alarcon-Martin, E; Colmenero, JD; Caruz, A; Fibla, J; Real, LM; Royo, JL

    Toll Like Receptor 2 promoter -196 to -174 deletion affects CD4 levels along HIV infection progression.

    JOURNAL OF INFECTIOUS DISEASES 222 2007-2011. .

    [doi:10.1093/infdis/jiaa327]

  • Laplana, M; Yuguero, O; Fibla, J

    Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients.

    PLOS ONE 15 -. .

    [doi:10.1371/journal.pone.0243598]

  • Aguilar-Jimenez, W; Zapata, W; Rivero-Juarez, A; Pineda, JA; Laplana, M; Taborda, NA; Biasin, M; Clerici, M; Caruz, A; Fibla, J; Rugeles, MT

    Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability

    Infection Genetics And Evolution 73 276-286. .

    [doi:10.1016/j.meegid.2019.05.014]

  • Laplana, M; Royo, JL; Fibla, J

    Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis

    Gene 678 384-394. .

    [doi:10.1016/j.gene.2018.08.017]

  • Herrero R; Real LM; Rivero-Juárez A; Pineda JA; Camacho Á; Macías J; Laplana M; Konieczny P; Márquez FJ; Souto JC; Soria JM; Saulle I; Lo Caputo S; Biasin M; Rivero A; Fibla J; Caruz A

    Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

    Genes and Immunity 16 134-141. .

    [doi:10.1038/gene.2014.71]

  • Laplana, M.; Royo, J. L.; Garcia, L. F.; Aluja, A.; Gomez-Skarmeta, J. L.; Fibla, J.

    SIRPB1 copy-number polymorphism as candidate quantitative trait locus for impulsive-disinhibited personality

    GENES BRAIN AND BEHAVIOR 13 653-662. .

    [doi:10.1111/gbb.12154]

  • Laplana, M; Sanchez-de-la-Torre, M; Puig, T; Caruz, A; Fibla, J

    Vitamin-D pathway genes and HIV-1 disease progression in injection drug users

    Gene 545 163-169. .

    [doi:10.1016/j.gene.2014.04.035]

  • Laplana M; Royo JL; Aluja A; López R; Heine-Sunyer D; Fibla J

    Absence of substantial copy number differences in a pair of monozygotic twins discordant for features of autism spectrum disorder.

    Case reports in genetics 2014 516529-516529. .

    [doi:10.1155/2014/516529]

  • Laplana, Marina; Caruz, Antonio; Antonio Pineda, Juan; Puig, Teresa; Fibla, Joan

    Association of BST-2 Gene Variants With HIV Disease Progression Underscores the Role of BST-2 in HIV Type 1 Infection

    JOURNAL OF INFECTIOUS DISEASES 207 411-419. .

    [doi:10.1093/infdis/jis685]

Projectes

  • MEjora del DIagnóstico en CÁncer de PÁncreas (MEDI-CAPA)
  • Vías de señalización para desarrollo y muerte celular en el miocardio: estudio integrativo para su comprensión e identificación de dianas terapéuticas.
  • FACTOR GENETIC EN LA PERSONALITAT IMPULSIVA-DESINHIBIDA. ANALISIS DE LA DISTRIBUCIO DE VARIANTS DE NOMBRE DE COPIA EN SUBJECTES AMB ALTA PUNTUACIO PER IMPULSIVITAT-DESINHIIBICIO: EST